Solid Biosciences (SLDB) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 10.71% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -0.31% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -23.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.10% |
| Dec 31, 2025 | -24.42% |
| Sep 30, 2025 | -11.41% |
| Jun 30, 2025 | -14.25% |
| Mar 31, 2025 | -9.74% |
| Dec 31, 2024 | -9.77% |
| Sep 30, 2024 | -9.72% |
| Jun 30, 2024 | -8.63% |
| Mar 31, 2024 | -5.03% |
| Dec 31, 2023 | -6.69% |
| Sep 30, 2023 | -7.39% |
| Jun 30, 2023 | -8.29% |
| Mar 31, 2023 | -7.47% |
| Dec 31, 2022 | -6.05% |
| Sep 30, 2022 | -18.01% |
| Jun 30, 2022 | -16.66% |
| Mar 31, 2022 | -20.19% |
| Dec 31, 2021 | -14.73% |
| Sep 30, 2021 | -4.62% |
| Jun 30, 2021 | 2.85% |
| Mar 31, 2021 | 19.09% |
| Dec 31, 2020 | 49.73% |